ChimeriVax-West Nile vaccine.
作者信息
Hall Roy A, Khromykh Alexander A
机构信息
School of Molecular and Microbial Sciences, The University of Queensland, St Lucia, Queensland 4072, Australia.
出版信息
Curr Opin Mol Ther. 2007 Oct;9(5):498-504.
PMID:17932814
Abstract
Acambis (formerly Peptide Therapeutics) is developing ChimeriVax-West Nile, a recombinant live-attenuated vaccine which incorporates their ChimeriVax platform technology, for the potential prevention of West Nile virus infection [373463], [328969]. A phase II clinical trial to assess the safety, tolerability and immunogenicity of different doses of ChimeriVax-West Nile is underway [642090], [775386].
摘要
Zotero 插件